UCSFDGIM

Excellence in providing primary and preventive health care, conducting innovative research, and training the best future doctors.

[UCSFDGIM @UCSFDGIM]

What did a multi-phase quality improvement initiative led by @ucsfdgim's Julci Areza, Atrejo Patridge, and @janejih learn about identifying transportation barriers and implementing transportation support interventions for patients with chronic conditions?
https://t.co/6mjKh74BcY

[UCSFDGIM @UCSFDGIM]

@LisaRotenstein and colleagues explain how accountable care organizations gave primary care physicians responsibility for managing overall patient care and achieving quality targets — without improving the PCP experience as promised.

https://t.co/NotGBQMKa0

[Lisa Rotenstein MD @LisaRotenstein]

In @NEJM today, Nick Stine, @Bruce_Landon and I describe how shared savings ACOs did not fundamentally change the physician experience despite the promise they held, and concrete suggestions to enhance the PCP experience of value based care
https://t.co/INbyVsj22q

[JAMA+ Trials @JAMAplusTrials]

🔖 This October's Trial Theme of the Month focuses on extension studies in #ClinicalTrials, where long-term findings depend on how comparison groups are defined and how attrition and selection bias are handled.

🔗 Read the latest editorial: https://t.co/y1eReZJpS5

[UCSFDGIM @UCSFDGIM]

How can digital health any AI transform cardio-kidney health in the Americas?

New perspective from @UCSFDGIM’s @Idasim, Sandeep Kishore, and colleagues:

https://t.co/nkoaef22Ne

[UCSFDGIM @UCSFDGIM]

From @UCSFDGIM faculty Mia Williams, @mitchellfeldma2, and colleagues:

Given the importance of sponsorship for career advancement in academic medicine, how do leaders think about and use sponsorship?

https://t.co/EUSkFoSV0q

[UCSFDGIM @UCSFDGIM]

What makes a clinical trial a "pragmatic" trial? And how many self-designated pragmatic trials are successful in generating evidence for real-world decision-making?

From @AlisonHuangMD, Thomas Travison, and Dereku Angus, this month in JAMA+ Trials: https://t.co/laPYT7hHTF

[UCSFDGIM @UCSFDGIM]

What can we learn from a patient tech testing panel in primary care practice?

Tech testing should draw on diverse patients by language, technology usage, and literacy to ensure digital interventions are equitably designed.

From @janejih and colleagues: https://t.co/RTfKIf8q39

[UCSFDGIM @UCSFDGIM]

Congratulations to Nhung Nguyen, PhD, PharmD, selected by the UCSF Haile T. Debas Academy of Medical Educators for Excellence in Teaching for 2025-2026!

Sometimes great clinical scientists are also outstanding teachers--we look forward to more of both from @NguyenHEARTYlab.

[UCSFDGIM @UCSFDGIM]

Findings from a randomized trial by UCSF DGIM and SCLC investigator @MayaVijayaragh1 and team indicate that higher-intensity interventions are needed to maintain smoke-free homes and support smoking cessation in permanent supportive housing.

https://t.co/THQ4o8zU0M

[UCSFDGIM @UCSFDGIM]

From @LisaRotenstein and colleagues:
https://t.co/f2NTj1bfrA

"The erosion of trust between physicians and patients reflects our history, our systems, and our collective choices. But it is not inevitable...."

[Society of General Internal Medicine (SGIM) @SocietyGIM]

🎉 Congratulations to our #SGIM26 Award Winner! 🎉

Please join us in celebrating Mitchell D. Feldman, MD, MPhil, recipient of the ACLGIM Chief’s Recognition Award. His outstanding work exemplifies excellence in general internal medicine.

👏 Help us congratulate Mitchell in the comments!

#SGIM26 #AwardWinner #AcademicMedicine #InternalMedicine

[Alka Kanaya @alka_kanaya]

Happy to share our new NIH-funded MOSAAIC Study design and methods paper

A new Asian American, Native Hawaiian, Pacific Islander longitudinal cohort

https://t.co/qdvSzH7ihF

@NIH @fredhutch @UW @nyulangone @UChicago @UHawaiiNews @StanfordMed @FoxChaseCancer @TempleUniv

[JAMA @JAMA_current]

Today, the JAMA Network launches @JAMAplusTrials, a new online platform that highlights the vision, innovation, and resilience of clinical trial research.

Designed for clinicians, investigators, trainees, and others engaged in clinical research worldwide, JAMA+ Trials is an interdisciplinary resource for enhancing insights and promoting dialogue in clinical trial research. 🧵

[UCSFDGIM @UCSFDGIM]

Is attending a historically Black college or university vs a predominantly White institution associated with later-life cognitive health for Black adults in the US?

New research from @UCSFDGIM investigator Marilyn Thomas published in @JAMANetworkOpen:

https://t.co/j0kLT03P9X

[UCSFDGIM @UCSFDGIM]

For graduating IM & med/peds residents looking to expand skills as clinicians/educators, we are still accepting apps for our Clinician Educator Fellowship! This program grants protected time to explore academic areas of interest while doing primary care. https://t.co/UwgkJIs74I

[Alison Huang, MD, MAS @AlisonHuangMD]

Glad to discuss this widespread symptom in older adults.

For most, nocturia doesn’t lend itself to a single magic bullet....

[Alison Huang, MD, MAS @AlisonHuangMD]

Neither panacea nor poison: the swinging pendulum of menopausal hormone therapy

[Nhung Nguyen @NguyenHEARTYlab]

🚨 New from our HEARTY Lab! Our new publication uncovers real-time predictors of nicotine vaping, cannabis vaping, and same-occasion co-vaping among young adults

[Alison Huang, MD, MAS @AlisonHuangMD]

Our @UCSFDGIM @UCSF_DOCIT faculty investigator @LisaRotenstein sharing her findings about understaffed physician teams with colleagues and journals at #SGIM25: